跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PENTAMIDINE ISETIONATE FOR INJECTION BP
Authorized
STANDARD
PENTAMIDINE ISETIONATE FOR INJECTION BP
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f94e6394f31a7d64
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
f94e6394f31a7d64
Drug Approval Canada Name
PENTAMIDINE ISETIONATE FOR INJECTION BP
Product Name
PENTAMIDINE ISETIONATE FOR INJECTION BP
Status
Marketed
Status Date
2021-10-14
Original Market Date
2021-10-14
Din
02517663
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Prescription
Ahfs
08:30.92
Atc Original
P01CX01 PENTAMIDINE ISETHIONATE
Atc Name
p 01 cx 01
Aig Number
0152223001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
PENTAMIDINE ISETIONATE
300 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f94e6394f31a7d64
Type
Standard
Back to Health Canada Approvals